|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J,
Murray T and Thun MJ: Cancer statistics 2008. CA Cancer J Clin.
58:71–96. 2008. View Article : Google Scholar
|
|
2
|
Widschwendter M and Jones PA: DNA
methylation and breast carcinogenesis. Oncogene. 21:5462–5482.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pongtheerat T, Pakdeethai S, Purisa W,
Chariyalertsak S and Petmitr S: Promoter methylation and genetic
polymorphism of glutathione S-transferase P1 gene (GSTP1) in Thai
breast-cancer patients. Asian Pac J Cancer Prev. 12:2731–2734.
2011.PubMed/NCBI
|
|
4
|
Lu S, Wang Z, Cui D, Liu H and Hao X:
Glutathione S-transferase P1 Ile105Val polymorphism and breast
cancer risk: a meta-analysis involving 34,658 subjects. Breast
Cancer Res Treat. 125:253–259. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jones PA and Baylin SB: The epigenomics of
cancer. Cell. 128:683–692. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fraga MF, Herranz M, Espada J, et al: A
mouse skin multistage carcinogenesis model reflects the aberrant
DNA methylation patterns of human tumours. Cancer Res.
64:5527–5534. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Esteller M: Epigenetics in cancer. N Eng J
Med. 358:1148–1159. 2008. View Article : Google Scholar
|
|
8
|
Silvestrini R, Veneroni S, Benini E, et
al: Expression of p53 glutathione S-transferase-pi and Bcl-2
proteins and benefit from adjuvant radiotherapy in breast cancer. J
Natl Cancer Inst. 89:639–645. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Esteller M, Corn PG, Urena JM, Gabrielson
E, Baylin SB and Herman JG: Inactivation of glutathione
S-transferase P1 gene by promoter hypermethylation in human
neoplasia. Cancer Res. 58:4515–4518. 1998.PubMed/NCBI
|
|
10
|
Lee JS: GSTP1 promoter hypermethylation is
an early event in breast carcinogenesis. Virchows Arch.
450:637–642. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Millar DS, Ow KK, Paul CL, Russell PJ,
Molloy PL and Clark SJ: Detailed methylation analysis of the
glutathione S-transferase pi (GSTP1) gene in prostate cancer.
Oncogene. 18:1313–1324. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jerónimo C, Varzim G, Henrique R, et al:
I105V polymorphism and promoter methylation of the GSTP1 gene in
prostate adeno-carcinoma. Cancer Epidemiol Biomarkers Prev.
11:445–450. 2002.PubMed/NCBI
|
|
13
|
Chan QK, Khoo US, Chan KY, et al: Promoter
methylation and differential expression of pi-class glutathione
S-transferase in endometrial carcinoma. J Mol Diagn. 7:8–16. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tokumaru Y, Harden SV, Sun DI, Yamashita
K, Epstein JI and Sidransky D: Optimal use of a panel of
methylation markers with GSTP1 hypermethylation in the diagnosis of
prostate adenocarcinoma. Clin Cancer Res. 10:5518–5522. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhong S, Tang MW, Yeo W, Liu C, Lo YM and
Johnson PJ: Silencing of GSTP1 gene by CpG island DNA
hypermethylation in HBV-associated hepatocellular carcinomas. Clin
Cancer Res. 8:1087–1092. 2002.PubMed/NCBI
|
|
16
|
Arai T, Miyoshi Y, Kim SJ, Taguchi T,
Tamaki Y and Noguchi S: Association of GSTP1 CpG islands
hypermethylation with poor prognosis in human breast cancers.
Breast Cancer Res Treat. 100:169–176. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hoque MO, Feng Q, Toure P, et al:
Detection of aberrant methylation of four genes in plasma DNA for
the detection of breast cancer. J Clin Oncol. 24:4262–4269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Parrella P, Poeta ML, Gallo AP, et al:
Nonrandom distribution of aberrant promoter methylation of
cancer-related genes in sporadic breast tumors. Clin Cancer Res.
10:5349–5354. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shinozaki M, Hoon DS, Giuliano AE, Hansen
NM, Wang HJ, Turner R and Taback B: Distinct hypermethylation
profile of primary breast cancer is associated with sentinel lymph
node metastasis. Clin Cancer Res. 11:2156–2162. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Henderson CJ, McLaren AW, Moffat GJ, Bacon
EJ and Wolf CR: Pi-class glutathione S-transferase: regulation and
function. Chem Biol Interact. 111–112:69–82. 1998.PubMed/NCBI
|
|
21
|
Hu X, Xia H, Srivastava SK, Pal A, Awasthi
YC, Zimniak P and Singh SV: Catalytic efficiencies of allelic
variants of human glutathione S-transferase P1-1 toward
carcinogenic anti-diol epoxides of benzo[c]phenanthrene and
benzo[g]chrysene. Cancer Res. 58:5340–5343. 1998.PubMed/NCBI
|
|
22
|
Antognelli C, Del Buono C, Ludovini V,
Gori S, Talesa VN, Crinò L, Barberini F and Rulli A: CYP17, GSTP1,
PON1 and GLO1 gene polymorphisms as risk factors for breast cancer:
an Italian case-control study. BMC Cancer. 9:1152009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Reding KW, Weiss NS, Chen C, et al:
Genetic polymorphisms in the catechol estrogen metabolism pathway
and breast cancer risk. Cancer Epidemiol Biomarkers Prev.
18:1461–1467. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
MARIE-GENICA Consortium on Genetic
Susceptibility for Menopausal Hormone Therapy Related Breast Cancer
Risk: Genetic polymorphisms in phase I and phase II enzymes and
breast cancer risk associated with menopausal hormone therapy in
postmenopausal women. Breast Cancer Res Treat. 119:463–474. 2010.
View Article : Google Scholar
|
|
25
|
Saxena A, Dhillon VS, Raish M, et al:
Detection and relevance of germline genetic polymorphisms in
glutathione S-transferases (GSTs) in breast cancer patients from
northern Indian population. Breast Cancer Res Treat. 115:537–543.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang BL, Sun T, Zhang BN, et al:
Polymorphisms of GSTP1 is associated with differences of
chemotherapy response and toxicity in breast cancer. Chin Med J
(Engl). 124:199–204. 2011.PubMed/NCBI
|
|
27
|
Singletary SE, Allred C, Ashley P, et al:
Revision of the American Joint Committee on Cancer staging system
for breast cancer. J Clin Oncol. 20:3628–3636. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sobin LH and Fleming ID: TNM
classification of Malignant Tumors, 5th edition (1997). Union
Internationale Contre le Cancer and the American Joint Committee on
Cancer. Cancer. 80:1803–1804. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Strange RC, Spiteri MA, Ramachandran S and
Fryer AA: Glutathione-S-transferase family of enzymes. Mutat Res.
482:21–26. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kopps S, Angeli-Greaves M, Blaszkewicz M,
et al: Glutathione S-transfrease P1 Ile105Val polymoprphism in
occupationally exposed bladder cancer cases. J Toxicol Environ
Health A. 71:898–901. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bernardini S, Bellincampi L, Ballerini S,
et al: Glutathione S-transferase P1 *C allelic variant increases
susceptibility for late-onset Alzheimer disease: association study
and relationship with apolipoprotein E epsilon4 allele. Clin Chem.
51:944–951. 2005.
|
|
32
|
Johansson AS, Stenberg G, Widersten M and
Mannervik B: Structure activity relationships and thermal stability
of human glutathione transferase P1-1 governed by the H-site
residue 105. J Mol Biol. 278:687–698. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Baylin SB, Belinsky SA and Herman JG:
Aberrant methylation of gene promoters in cancer - concepts,
misconcepts, and promise. J Natl Cancer Inst. 92:1460–1461. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gazzoli I, Loda M, Garber J, Syngal S and
Kolodner RD: A hereditary nonpolyposis colorectal carcinoma case
associated with hypermethylation of the MLH1 gene in normal tissue
and loss of heterozygosity of the unmethylated allele in the
resulting microsatellite instability-high tumor. Cancer Res.
62:3925–3928. 2002.
|
|
35
|
Adler V, Yin Z, Fuchs SY, et al:
Regulation of JNK signaling by GSTp. EMBO J. 18:1321–1334. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kinzler KW and Vogelstein B:
Cancer-susceptibility genes. Gatekeepers and caretakers. Nature.
386:761–763. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lee WH, Morton RA, Epstein JI, et al:
Cytidine methylation of regulatory sequences near the pi-class
glutathione S-transferase gene accompanies human prostatic
carcinogenesis. Proc Natl Acad Sci USA. 91:11733–11737. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Brooks JD, Weinstein M, Lin X, et al: CG
island methylation changes near the GSTP1 gene in prostatic
intraepithelial neoplasia. Cancer Epidemiol Biomark Prev.
7:531–536. 1998.PubMed/NCBI
|
|
39
|
Tserga A, Michalopoulos NV, Levidou G,
Korkolopoulou P, Zografos G, Patsouris E and Saetta AA: Association
of aberrant DNA methylation with clinicopathological features in
breast cancer. Oncol Rep. 27:1630–1638. 2012.PubMed/NCBI
|
|
40
|
Matuschek C, Bölke E, Lammering G, et al:
Methylated APC and GSTP1 genes in serum DNA correlate with the
presence of circulating blood tumor cells and are associated with a
more aggressive and advanced breast cancer disease. Eur J Med Res.
15:277–286. 2010.PubMed/NCBI
|
|
41
|
Fishman J, Osborne MP and Telang NT: The
role of estrogen in mammary carcinogenesis. Ann NY Acad Sci.
768:91–100. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Cavalieri EL, Stack DE, Devanesan PD, et
al: Molecular origin of cancer: catechol estrogen-3,4-quinones as
endogenous tumor initiators. Proc Natl Acad Sci USA.
94:10937–10942. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lee JS, Lo PK, Fackler MJ, Argani P, Zhang
Z, Garrett-Meyer E and Sukumar S: A comparative study of Korean
with Caucasian breast cancer reveals frequency of methylation in
multiple genes correlates with breast cancer in young, ER,
PR-negative breast cancer in Korean women. Cancer Biol Ther.
6:1114–1120. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Cho YH, Shen J, Gammon MD, Zhang YJ, et
al: Prognostic significance of gene-specific promoter
hypermethylation in breast cancer patients. Breast Cancer Res
Treat. 131:197–205. 2012. View Article : Google Scholar : PubMed/NCBI
|
